Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease

An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer disease, according to a report posted online today that will appear in the August print issue of Archives of Neurology.

Read the whole article on Physorg

More from Physorg